Delaware State Dental Society Endorses Five iCoreConnect Products
Rhea-AI Summary
iCoreConnect Inc. (NASDAQ: ICCT) has secured a new endorsement agreement with the Delaware State Dental Society (DSDS), marking another milestone in its growth among state dental associations. This partnership adds to iCoreConnect's over 180 product endorsement agreements across various states, reinforcing its position in the dental industry.
The DSDS has endorsed five iCoreConnect products: iCoreVerify, iCoreVerifyPro, iCoreRx, iCoreClaims, and iCorePay. These solutions aim to enhance productivity and efficiency for dental professionals. With this addition, iCoreConnect now serves approximately 155,000 dental professionals across the U.S., utilizing these endorsements for product distribution and lead generation.
Positive
- Secured new endorsement agreement with Delaware State Dental Society
- Now holds over 180 product endorsement agreements across various states
- Five iCoreConnect products endorsed by DSDS
- Serves approximately 155,000 dental professionals across the U.S.
- Endorsements used as key tools for product distribution and lead generation
Negative
- None.
News Market Reaction
On the day this news was published, ICCT gained 9.09%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
OCOEE, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ: ICCT) (“iCore” or the “Company”), a leading provider of cloud-based software and technology solutions, announced a new endorsement agreement with the Delaware State Dental Society (DSDS). This partnership marks another milestone in iCoreConnect’s continued growth among state dental associations nationwide.
With this endorsement, DSDS joins numerous other state dental associations that have recognized the value of iCoreConnect’s innovative solutions. iCoreConnect now holds over 180 product endorsement agreements across various states, solidifying its reputation as a trusted partner in the dental industry.
Robert McDermott, CEO of iCoreConnect, commented, “DSDS, along with other state dental associations, plays a crucial role in advocacy, education, practice management, and public health initiatives. This endorsement highlights DSDS’s commitment to advancing the dental profession and enhancing patient care in Delaware.”
The endorsed iCoreConnect products include:
- iCoreVerify - Automated insurance verification
- iCoreVerifyPro - Full-service verifications
- iCoreRx - Cloud ePrescribing
- iCoreClaims - Dental claims and billing
- iCorePay - Statements, payments, and billing
Dr. Tom Howley, Executive Director of DSDS, shared his enthusiasm for the collaboration, stating, “We are excited to announce this endorsement. iCoreConnect’s cutting-edge solutions enhance the productivity and efficiency of our members. Their proven success with state associations nationwide makes us eager to welcome them to Delaware.”
iCoreConnect’s involvement in continuing education, networking, and practice management support positions it as a valuable partner for state dental associations. With its growing number of endorsements, the company now serves approximately 155,000 dental professionals across the U.S., using these endorsements as key tools for product distribution and lead generation.
For more information about iCoreConnect or to schedule a demo, visit iCoreConnect.com.
About iCoreConnect
iCoreConnect Inc. is a market leader in cloud-based software and technology solutions designed to improve workflow productivity and profitability in the enterprise, healthcare and dental sectors. Through its innovative platform of applications and services, iCoreConnect helps organizations optimize their operations and achieve better business outcomes.
About the Delaware State Dental Society
The Delaware State Dental Society (DSDS) represents
Forward-Looking Statements
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. The Company has attempted to identify forward-looking statements by terminology including ‘believes,’ ‘estimates,’ ‘anticipates,’ ‘expects,’ ‘plans,’ ‘projects,’ ‘intends,’ ‘potential,’ ‘may,’ ‘could,’ ‘might,’ ‘will,’ ‘should,’ ‘approximately’ or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under Item 1A. “Risk Factors” in the Company’s most recently filed Form 10-K filed with the Securities and Exchange Commission (“SEC”) and updated from time to time in its Form 10-Q filings and in its other public filings with the SEC. Any forward-looking statements contained in this release speak only as of its date. The Company undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Investor Contacts:
IR@icoreconnect.com
888.810.7706, ext 5